What is the recommended treatment for Fasciolopsis buski infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment for Fasciolopsis buski

The recommended treatment for Fasciolopsis buski infection is praziquantel 25 mg/kg orally three times daily for 1-2 days. 1

Treatment Regimen

The most recent UK guidelines (2025) provide clear dosing recommendations for fasciolopsiasis:

  • Praziquantel 25 mg/kg three times daily for 2 days 1

This regimen is supported by multiple case reports demonstrating excellent efficacy. A 2026 case report successfully treated a patient with praziquantel 75 mg/kg total dose divided into three doses over 1 day (25 mg/kg three times daily), with complete parasite clearance documented by day 3 2. Another case in a malnourished child achieved cure with praziquantel at standard dosing 3.

Alternative Dosing Considerations

Field trial data from endemic areas suggests that lower single doses may be effective for less severe infections:

  • A randomized trial in Thailand found that 15 mg/kg as a single dose achieved adequate cure rates with fewer side effects compared to 25 or 40 mg/kg doses 4
  • However, for established infections with documented adult worms, the multi-day regimen at 25 mg/kg three times daily remains the guideline-recommended approach 1

Clinical Response and Follow-up

Expect the following treatment response:

  • Adult worms are typically expelled in stool within 2-3 days after treatment initiation 2, 5
  • Stool examination should become negative for eggs and adult worms by day 3-4 post-treatment 2
  • Symptoms (abdominal discomfort, diarrhea, anorexia) resolve within days of parasite clearance 2

Important Clinical Caveats

Critical distinction from Fasciola species: While F. buski eggs are morphologically identical to Fasciola hepatica and F. gigantica eggs, the treatment differs fundamentally. Fasciola species are resistant to praziquantel and require triclabendazole 6. Accurate species identification is essential—F. buski is an intestinal fluke found in duodenum/jejunum, while Fasciola species localize to biliary ducts.

Side effects of praziquantel are generally mild and transient, including headache, dizziness, nausea, abdominal discomfort, and transient diarrhea 4. Higher doses (40 mg/kg) produce more side effects without improved efficacy 4.

Unusual presentations: While F. buski typically parasitizes the small intestine, rare biliary tract infections have been reported 7, 8. These cases may require endoscopic extraction in addition to praziquantel therapy.

Endemic Context and Prevention

F. buski transmission occurs through consumption of contaminated raw or undercooked aquatic plants (water chestnuts, water lily stems, caltrop, water cress) 2, 9, 5. In endemic areas like parts of India and Indonesia, prevalence can exceed 10% in certain villages 5, 4. Post-treatment surveillance and health education about avoiding raw aquatic plants are essential to prevent reinfection 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.